By Lena Welch | 7/10/13 12:50 PM
More than 15,000 children and 15,000 adults are diagnosed with type 1 diabetes (T1D) each year. It can strike anyone at any age, causing dependence on injected or infused insulin for life and carrying the constant threat of complications. Major League Lacrosse is partnering with JDRF, the leading global, charitable organization funding T1D research to raise funds and awareness at the 2013 MLL All-Star Game, presented by Moe’s Southwest Grill.
This is the second season MLL partners with JDRF. In 2011, JDRF was the charity of the All-Star Game. The MLL raised $12,500 through the official game-worn and autographed jersey auction. A matching donation was made by The New Balance Foundation, doubling the proceeds to a total of $25,000 raised for JDRF to fund research to find better treatments through improved glucose control and a cure for T1D. The League and JDRF are looking to top their 2011 fundraising total to further advance important T1D research.
The All-Star Game July 13 at American Legion Memorial Stadium in Charlotte, N.C., will be the main focus of the summer partnership. JDRF will receive national exposure during the game, airing live on ESPN2 at 7 p.m.
Pre-game ceremonies at the All-Star Game will recognize JDRF and its dedication to T1D research. Special edition jerseys, which include the JDRF logo, will also be worn by players during the game, and later be auctioned to the public with proceeds going to JDRF, just as in 2011. Fans can also donate $5 to JDRF by texting “JDRF5” to 20222 and are encouraged to do so throughout the month of July.A final check with the total amount raised will be presented to JDRF at MLL Championship Weekend, presented by Smartlink, taking place August 24 and 25 in Philadelphia.
JDRF uses the funds raised by the MLL and others towork toward itsgoal of progressively removing the impact of T1D from people’s lives until there is a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. The funds raised by the MLL will help JDRF bring life-changing therapies to people with T1D, and ultimately, a cure for the disease.
More than 80 percent of JDRF’s expenditures directly support research and research-related education. JDRF has research projects in 17 countries totaling $530 million currently taking place. In 2012 alone, JDRF funded more than $110 million in T1D research and supported more than 50 clinical trials to evaluate new therapies and treatments. Since its founding in 1970, JDRF has awarded more than $1.7 billion to diabetes research. JDRF’s efforts have helped to significantly advance the care of people with this disease and have expanded the critical scientific understanding of T1D.
Some of JDRF’s research goals include delivering an automated low-glucose suspend artificial pancreas system to predict and prevent severe blood-glucose lows and a treat-too-range artificial pancreas system to automatically keep blood-glucose levels in a specified range. JDRF also seeks to explore the use of existing type 2 diabetes drugs to improve blood-glucose control in people with T1D.
In the long term, JRDF’s goals include providing insulin independence for more than a year through novel beta cell therapies, therapies that improve eye disease in people with T1D and therapies that prevent or delay the onset of insulin dependence for at least two years in people with autoantibodies for T1D. Furthermore, JDRF is exploring a glucose responsive insulin that will provide glycemic control with a single shot per day, as opposed to the six or more shots currently required by those with T1D.
T1D is an autoimmune disease that affects as many as three million children and adults and is potentially fatal. There is currently no cure. Those with T1D must test their blood sugar levels and are dependent on injected or infused insulin. T1D can cause a series of complications and health issues including kidney failure, amputation, blindness, stroke, and heart disease leading to heart attacks. JDRF supports research to improve the lives of those with T1D, develop medical advancements to prevent health complications, and eventually remove T1D completely from people’s lives.
Other partners of the MLL All-Star Game have included MetroLacrosse, Boys and Girls Club of America, Special Olympics of North America, Wounded Warrior Project (WWP), HEADstrong Foundation and Susan G. Komen Race for the Cure.
Tickets are now on sale for the 2013 MLL All-Star Game presented by Moe’s Southwest Grill on Ticketmaster.com or by calling 704-206-1515